These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31115306)

  • 41. Long-lasting humoral and cellular immune responses elicited by immunization with recombinant chimeras of the Plasmodium vivax circumsporozoite protein.
    Almeida AP; Dias MO; Vieira Cde A; Chávez-Olórtegui C; Gazzineli RT; Rodrigues MM; Fujiwara RT; Bruna-Romero O
    Vaccine; 2014 Apr; 32(19):2181-7. PubMed ID: 24582631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.
    Nardin E; Zavala F; Nussenzweig V; Nussenzweig RS
    Parassitologia; 1999 Sep; 41(1-3):397-402. PubMed ID: 10697892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
    Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
    Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opportunities for Typhoid Vaccination in India.
    Srinivasan M; Sindhu KN; John J; Kang G
    Indian Pediatr; 2019 Jun; 56(6):453-458. PubMed ID: 31278221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Towards a vaccine against malaria.
    McGregor IA
    Br J Biomed Sci; 1993 Mar; 50(1):35-42. PubMed ID: 8032294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.
    Doolan DL; Sedegah M; Hedstrom RC; Hobart P; Charoenvit Y; Hoffman SL
    J Exp Med; 1996 Apr; 183(4):1739-46. PubMed ID: 8666931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection conferred by typhoid fever against recurrent typhoid fever in urban Kolkata.
    Im J; Islam MT; Kim DR; Ahmmed F; Chon Y; Zaman K; Khan AI; Ali M; Sur D; Kanungo S; Dutta S; Bhattacharya SK; Dougan G; Holt KE; Marks F; Kim JH; Qadri F; Clemens JD
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008530. PubMed ID: 32804950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventing invasive salmonellosis in children through vaccination.
    Principi N; Esposito S
    Expert Rev Vaccines; 2016 Jul; 15(7):897-905. PubMed ID: 27140662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. International reference preparations of typhoid vaccine. Potency assay by the active mouse protection test with three different routes of immunization.
    Melikova EN; Lesnjak SV
    Bull World Health Organ; 1967; 37(4):575-9. PubMed ID: 5301738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlled field trials of killed oral typhoid and paratyphoid B vaccines and cell-free, chemical aerosol typhoid vaccine.
    Hejfec LB; Levina LA; Salmin LB; Antonova AA; Segal LS; Kuzminova ML; Slavina KM; Vasileva AV
    Dev Biol Stand; 1976; 33():93-7. PubMed ID: 821803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical case definitions and malaria vaccine efficacy.
    Rogers WO; Atuguba F; Oduro AR; Hodgson A; Koram KA
    J Infect Dis; 2006 Feb; 193(3):467-73. PubMed ID: 16388497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunity against typhoid fever. I. Wright's anti-typhoid vaccination, 1896 to 1979].
    Milhomem AM; Suassuna I
    Mem Inst Oswaldo Cruz; 1982; 77(1):93-120. PubMed ID: 6755159
    [No Abstract]   [Full Text] [Related]  

  • 53. Reducing empiricism in malaria vaccine design.
    Moorthy VS; Kieny MP
    Lancet Infect Dis; 2010 Mar; 10(3):204-11. PubMed ID: 20185099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccines for preventing typhoid fever.
    Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The development of the RTS,S malaria vaccine candidate: challenges and lessons.
    Ballou WR
    Parasite Immunol; 2009 Sep; 31(9):492-500. PubMed ID: 19691554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interchangeability of Hepatitis A boosters, Avaxim and Vaqta, in healthy adults following a primary dose of the combined typhoid/Hepatitis A vaccine Viatim.
    Ekwall E; Ulgemo A; Watson M; Boisnard F; Thomas S; Goullet F
    Vaccine; 2006 May; 24(20):4450-7. PubMed ID: 16621186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of oral killed typhoid vaccine.
    Chuttani CS; Prakash K; Vergese A; Sharma U; Singha P; Ray BG
    Bull World Health Organ; 1971; 45(4):445-50. PubMed ID: 4948415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of BCG vaccine on immune responses induced by vi polysaccharide typhoid fever vaccination: an explorative randomized trial.
    Blok BA; Arts RJW; van Crevel R; Aaby P; Joosten LAB; Benn CS; Netea MG
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1177-1184. PubMed ID: 32065303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper.
    Laurens MB; Sirima SB; Rotrosen ET; Siribie M; Tiono A; Ouedraogo A; Liang Y; Jamka LP; Kotloff KL; Neuzil KM
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S59-S66. PubMed ID: 30845330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.